Neuroactive steroids, compositions, and uses thereof
US10759828B2 · kind B2 · utility
13Cited by
15References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2018 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Aug 28, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J75/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided according to Formula (I): and pharmaceutically acceptable salts thereof, wherein Z is a group of the formula (i), (ii), (iii), (iv), or (v): and wherein L1, L2, L3, X1, X2, Y, RZ4, RZ5, RZ6, n, R1, R2, R3a, R3b, R4a, R4b, R6a, R6b, R7a, R7b, R11a, R11b, R14, R17, R19, R20, R23a, R23b, and R24 are as defined herein, and pharmaceutical compositions thereof. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of CNS-related conditions in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.